Drug accumulation becomes more pronounced when a new dose is given before the preceding drug has been effectively eliminated. A shorter interval leaves more residual drug in circulation or tissues, so each subsequent dose adds to what remains. Extending the interval gives elimination more opportunity to reduce residual amounts and can limit the rise in concentration.
Absorption, distribution, metabolism, and excretion jointly shape accumulation. Absorption determines how drug enters the body, while distribution affects whether it remains in circulation or moves into tissues. Metabolism and excretion remove drug, and clearance summarizes this elimination capacity. Changes in any of these processes can alter concentrations during repeated dosing.
Clearance indicates how efficiently the body removes a drug and therefore helps predict the concentration reached during continued exposure. Lower clearance allows more drug to remain between doses, increasing the likelihood of accumulation. Considering clearance alongside dose and dosing interval supports more informed expectations about steady-state concentrations and potential toxicity.
Both repeated doses and continuous exposure can increase the amount of drug present when input exceeds effective elimination over a given period. Repeated dosing creates successive additions separated by dosing intervals, whereas continuous exposure supplies drug without those discrete intervals. Comparing the exposure pattern with elimination helps explain the resulting concentration profile.
Assessment should consider the dose, dosing interval or exposure pattern, effective elimination time, and the drug’s absorption, distribution, metabolism, excretion, and clearance. Concentrations in circulation or relevant tissues can then be interpreted in relation to repeated exposure. This framework helps evaluate whether levels are approaching steady state or becoming excessive.
Monitoring is particularly important during long-term treatment and when a drug has a narrow safety margin, because residual drug can progressively influence therapeutic effects and toxicity. Therapeutic drug monitoring provides concentration information that can be compared with the intended treatment context. The findings support evaluation of whether exposure remains appropriate as dosing continues.